Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes. Qdata spans ophthalmology, neurology, and urology to help unlock quality insights across the entire drug and device development cycle.
Exclusive Insights into this Population
Only found here from the American Academy of Neurology Axon Registry®
Granular Understanding of Signs & Symptoms from Patient Notes
Cardinal signs to inform disease progression
Unique View into Treatments and Outcomes
Including motor complications of dopaminergic therapy
By the Numbers
Total de-identified patients with Parkinson’s Disease*
Average length of follow-up for total patients
Contributing American Academy of Neurology clinicians
**Defined as 1+ Parkinson’s ICD code and 1+ claim from an open or closed enrollment period AND a second Parkinson’s ICD Code 6+ months after the first OR 2+ mentions of Parkinson's cardinal signs OR 1+ mention of DBS surgery in notes. Data as of April 2023. Data counts represented are subject to change. Data counts for research purposes are dependent on project scope, feasibility and integration status.
Meet with a Qdata Expert or Request a Data Count
Key Variables in Qdata Parkinson’s Disease
Curated variables are extracted from EHR data to be utilized based on your research needs.
Unstructured Data Enables Deeper Understanding
Verana Health applies clinician-informed algorithms to unstructured EHR data at scale to help extract key information such signs and symptoms including tremor, bradykinesia, rigidity and more.
This can give life sciences companies unprecedented insights into the treatments and outcomes of patients with Parkinson’s Disease beyond ICD codes.
of Medical Data Remains Unstructured
Read More About Qdata Parkinson’s Disease
Check out research, blogs and news related to our work in Parkinson’s Disease.
Talk to a Qdata Expert
Take a minute to submit your contact information and one of our team members will reach out to you.